Daniel Richardson

Daniel Richardson, MD, MSc, MA is an Associate Professor of Medicine in the Division of Hematology at the University of North Carolina at Chapel Hill School of Medicine. His research focuses on improving cancer care through patient-centered approaches and shared decision-making, particularly for older adults with hematologic malignancies.

• Undergraduate: Ohio University
• Medical School: Ohio State University
• Masters Of Arts: Biola University
• Masters Of Science: University of North Carolina at Chapel Hill
• Residency: Ohio State University
• Fellowship: University of North Carolina at Chapel Hill

Dr. Richardson's research primarily focuses on acute and chronic leukemia, myelodysplastic syndromes, and patient-centered care. His work aims to develop interventions that align cancer treatment with patient values, goals, and preferences. He has developed methods to assess patient values at the point of care and evaluate how quantitative value elicitation instruments can improve shared decision-making regarding chemotherapy. His research group is working to create tools that help clinicians better understand what matters most to their patients, particularly older adults with cancer.

Analysis of Dr. Richardson's recent publications reveals a strong focus on patient-centered care in hematologic malignancies, particularly acute myeloid leukemia (AML) in older adults. His work spans several key areas including genomic profiling of AML, patient decision-making tools, quality of life assessments, and home time metrics as meaningful outcomes. A significant portion of his research involves developing and testing values clarification tools to improve goal-concordant care. He has also explored the relationship between therapy intensity and patient-centered outcomes, contributing to the growing field of geriatric oncology.

Dr. Richardson actively collaborates with interdisciplinary teams across multiple institutions, working with oncologists, hematologists, geriatric specialists, and patient-centered outcomes researchers. His work often involves developing and testing clinical tools that can be implemented in real-world practice to improve patient-clinician communication and decision-making.